Resistant Super Bugs: Searching for the Molecular and Clinical Lifeline for Gram-Positive Infections

Sunday, September 16

Room: E353AB
Reception Time: 5:00 p.m. – 5:30 p.m.
Symposium Time: 5:30 p.m. – 7:30 p.m.

Supported by Targanta Therapeutics Corporation.

Welcome, and Experts Studio Roundtable
Louis B. Rice, MD (Chair)
Professor of Medicine
Case Western Reserve University School of Medicine
Cleveland, Ohio

Impact of Increasing Resistance in Community- and Hospital-Acquired Pathogens
Michael Rybak, PharmD
Director, Anti-Infective Research Laboratory
Professor of Pharmacy and Medicine
Wayne State University
Eugene Applebaum College of Pharmacy and Health Sciences
Detroit, Michigan

How Bacteria Become Resistant: The Rise of Superbugs
Robert C. Moellering, Jr., MD
Shields Warren-Mallinckrodt Professor of Medical Research
Harvard Medical School
Department of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Available and Emerging Agents to Combat Resistant Pathogens: Unmet Needs and Challenges in the Treatment of cSSSI and Bacteremia
Yehuda Carmeli, MD, MPH
Division of Epidemiology
Tel Aviv Medical Center
Tel Aviv, Israel
Division of Infectious Diseases
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, Massachusetts

Strategies to Limit Resistance
Henry F. (Chip) Chambers, MD
Professor of Medicine
Chief, Division of Infectious Diseases
University of California, San Francisco
San Francisco General Hospital
San Francisco, California

Symposium Registration Information:
On-site registration will be accommodated as space permits.

Updated as of: August 26, 2007